QIAGEN Digital Insights

QIAGEN Digital Insights is a leading provider of bioinformatics solutions that elevates molecular intelligence from bench to bedside. With a focus on advancing genomic and clinical knowledge, QIAGEN delivers expert-curated software and services to transform large datasets into actionable insights across various fields, including oncology, hereditary diseases, and clinical testing. Their diverse product range includes the QIAGEN CLC Genomics Workbench, QCI Interpret for Hereditary Disorders, and the Ingenuity Pathway Analysis (IPA) tool, which help researchers and clinicians analyze and visualize Next-Generation Sequencing (NGS) data effectively.

The brand is committed to empowering over 90,000 customers worldwide with state-of-the-art technology, complemented by robust biomedical knowledge bases like the Human Gene Mutation Database (HGMD) and extensive support services. Moreover, QIAGEN offers cloud-based solutions for high-throughput analyses and real-time interpretation, reinforcing their position at the forefront of genomics and molecular research. Through innovative solutions and a deep understanding of biology, QIAGEN Digital Insights fosters advancements in personalized medicine and drug discovery